Medinotec Inc. (MDNC): EBITDA
$1.18M
Year ended 2026-02-28
$781.1K
Trailing 12 months to 2026-08-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2026-02-28 | $1.18M | -64.0% | 2026-05-28, From 2025-03-01 |
| 2025-02-28 | $3.27M | +374.1% | 2026-05-28, From 2024-03-01 |
| 2024-02-29 | $688.8K | n/m | 2025-05-29, From 2023-03-01 |
| 2023-02-28 | -$185.0K | n/a | 2024-07-05, From 2022-03-01 |
EBITDA at similar companies
| Company | Year ended | EBITDA | Change YoY |
|---|---|---|---|
| Medinotec Inc. (MDNC) | 2026-02-28 | $1.18M | -64.0% |
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | -$3.96M | n/m |
| InspireMD, Inc. (NSPR) | 2025-12-31 | $426.39M | +73.0% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | -$2.90M | n/m |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | -$25.94M | n/m |
| INVO Fertility, Inc. (IVF) | 2025-12-31 | -$6.56M | n/m |
| Encision Inc (ECIA) | 2025-03-31 | -$90.6K | n/m |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | -$18.59M | n/m |
| Nephros Inc (NEPH) | 2025-12-31 | $1.29M | +812.1% |
Compare MDNC, NMTC, NSPR, NXGL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗